Practical guidance on assessing and treating lipid disorders to lower atherosclerotic cardiovascular disease risk.

Understand assessment with non-fasting lipids, investigation of secondary causes and 10-year ASCVD risk.

Determine statin prescribing by risk category with targets for reduction.

Recognise the need for other treatments when needed including ezetimibe, PCSK9 inhibitors and bempedoic acid.

Describe appropriate follow up and monitoring of statin therapy and side effects

Practical guidance on assessing and treating lipid disorders to lower atherosclerotic cardiovascular disease risk.Powered by the American College of Cardiology NCD Academy is available free for all healthcare professionals on MedShr, made possible by a partnership between the American College of Cardiology, the World Heart Federation and NCD Alliance, with Viatris as founding sponsor.

Dyslipidemia

NCD Academy

Cardiovascular Disease: Better Care by Reducing Risk

Learn evidence-based strategies for preventing, detecting, and managing heart disease. This self-paced online course focuses on key modifiable risk factors, emerging therapies, and guideline-based interventions, with practical tools for individualizing care, addressing the social determinants of health, and improving outcomes through multidisciplinary collaboration.

Janis Pereira

Evidence-based update on hypertension for clinicians, covering epidemiology, diagnosis, and management with the latest global guidelines and trial data.

Hypertension

Current best practices for diagnosing, monitoring, and managing diabetes to reduce cardiovascular and microvascular complications.

Diabetes

Evidence-based approaches to weight management and lifestyle change to improve cardiometabolic health.

Obesity, Diet and Physical Activity

Targeted interventions to address tobacco and alcohol use as modifiable drivers of cardiovascular disease.

Smoking and Alcohol

Key strategies for preventing stroke in atrial fibrillation through tailored anticoagulation and rhythm control.

Stroke Prevention in Atrial Fibrillation

Cardiovascular disease (CVD)—encompassing coronary heart disease, cerebrovascular disease, and related conditions—remains the leading global cause of morbidity and mortality with a projection of 23 million deaths annually by 2030.&nbsp; For generalists and cardiologists alike, staying at the forefront of prevention, early detection, and effective management strategies is essential. This NCD Academy Course aims to enrich clinical proficiency using evidence-based guidance and dynamic, interactive learning focused on reducing the risk of cardiovascular disease.&nbsp;As frontline healthcare professionals, you are uniquely positioned to reduce the burden of CVD through timely identification of modifiable risk factors, addressing them with informed therapeutic decisions, and effective patient engagement. This course integrates epidemiology, risk stratification, and guideline-driven management—including recent developments in hypertension, diabetes and obesity.&nbsp;Beyond risk using estimation tools like the Framingham Risk Score to quantify CHD risk, guiding both lifestyle and pharmacologic intervention, we will consider innovative therapies, such as SGLT-2 inhibitors and GLP-1 receptor agonists. Case-based scenarios will highlight how to tailor care—focusing on individual risk profiles, preferences, and social determinants of health.&nbsp;Embedded throughout are actionable learning points aligned with ACC Guidelines, encouraging healthcare professionals to collaborate within multidisciplinary teams to optimize outcomes. Whether diagnosing early hypertension in primary care or initiating lipid therapy after myocardial infarction, risk reduction is key to treating cardiovascular disease. This Independent Medical Education was developed independently by MedShr with the American College of Cardiology without any influence, input, or control from pharmaceutical companies or other ineligible commercial interests.